| Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. (NCT00742495) | Mundipharma Research Limited | 2009-03-01 |
| Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults (NCT00868218) | Rebecca Cox | 2009-03-01 |
| Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris (NCT01567592) | Medispec | 2009-03-01 |
| Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol (NCT01537692) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-03-01 |
| Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer (NCT00828022) | Soroka University Medical Center | 2009-03-01 |
| Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones (NCT00857090) | Omeros Corporation | 2009-03-01 |
| Effect of Riociguat on Bone Metabolism (NCT00855660) | Bayer | 2009-03-01 |
| Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017 (NCT00881569) | Daiichi Sankyo | 2009-03-01 |
| Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (NCT00873782) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Rotavirus Vaccine Produced by Butantan Institute (NCT00981669) | Butantan Institute | 2009-03-01 |
| Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood (NCT00856947) | Copenhagen Studies on Asthma in Childhood | 2009-03-01 |
| TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy. (NCT00828815) | Tibotec Pharmaceuticals, Ireland | 2009-03-01 |
| Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT00553150) | Alliance for Clinical Trials in Oncology | 2009-03-01 |
| Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects (NCT01129388) | Sanofi | 2009-03-01 |
| BTT1023 in Psoriasis (NCT00871598) | Biotie Therapies Corp. | 2009-03-01 |
| A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions (NCT00870974) | Institute for Neurodegenerative Disorders | 2009-03-01 |
| Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies (NCT00890955) | Lawrence Einhorn | 2009-03-01 |
| Pharmacokinetic Study of Two Oral Bemiparin Formulations (NCT00863577) | Rovi Pharmaceuticals Laboratories | 2009-03-01 |
| Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors (NCT00874042) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2009-03-01 |
| Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors (NCT01285453) | Novartis Pharmaceuticals | 2009-03-01 |
| Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer (NCT00851877) | University of Texas Southwestern Medical Center | 2009-03-01 |
| Sorafenib in Newly Diagnosed High Grade Glioma (NCT00884416) | University Hospital, Geneva | 2009-03-01 |
| Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome (NCT01127386) | Florian Strasser, MD ABHPM | 2009-03-01 |
| Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer (NCT00825734) | SCRI Development Innovations, LLC | 2009-03-01 |
| Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT00862082) | Proacta, Incorporated | 2009-03-01 |
| Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir (NCT00873223) | Novo Nordisk A/S | 2009-03-01 |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors (NCT00841191) | Centocor, Inc. | 2009-03-01 |
| Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers (NCT00870441) | Astellas Pharma Inc | 2009-03-01 |
| HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (NCT00839319) | University of Washington | 2009-03-01 |
| Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia (NCT00790127) | HemaQuest Pharmaceuticals Inc. | 2009-03-01 |
| Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma (NCT00826930) | Diffusion Pharmaceuticals Inc | 2009-03-01 |
| Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib (NCT01070706) | Jungsil Ro | 2009-03-01 |
| Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction (NCT01088191) | Mesoblast, Ltd. | 2009-03-01 |
| Mechanisms of the Relaxation Response in Elderly Hypertensives (NCT00913991) | National Center for Complementary and Integrative Health (NCCIH) | 2009-03-01 |
| Effect of Red Raspberry Consumption on Fasting Oxidative Stress Biomarkers (NCT00876811) | University of Toronto | 2009-03-01 |
| Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00871182) | Pearl Therapeutics, Inc. | 2009-03-01 |
| Temsirolimus and Radiation for Non-Small Cell Lung Cancer (NCT00796796) | Washington University School of Medicine | 2009-03-01 |
| Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects (NCT00867880) | Cumberland Pharmaceuticals | 2009-03-01 |
| Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions (NCT01645410) | Dr. Reddy's Laboratories Limited | 2009-03-01 |
| A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects (NCT00854659) | Abbott | 2009-03-01 |
| Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT (NCT01106066) | Samsung Medical Center | 2009-03-01 |
| Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2 (NCT00810303) | University Medicine Greifswald | 2009-03-01 |
| Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer (NCT00931450) | Institut Català d'Oncologia | 2009-03-01 |
| Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation (NCT00905762) | Bausch & Lomb Incorporated | 2009-03-01 |
| Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (NCT00888043) | Herbert Hurwitz, MD | 2009-03-01 |
| Effect of Food Intake on Pharmacokinetic Profiles of Z-338 (NCT00920998) | Astellas Pharma Inc | 2009-03-01 |
| Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors (NCT00880308) | Novartis Pharmaceuticals | 2009-03-01 |
| Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers (NCT02220660) | Boehringer Ingelheim | 2009-03-01 |
| Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis (NCT00818948) | Amgen | 2009-03-01 |
| Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets (NCT01226056) | Southern Europe New Drug Organization | 2009-03-01 |
| Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) (NCT00951457) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2009-03-01 |
| Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure (NCT01218464) | Beijing 302 Hospital | 2009-03-01 |
| External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer (NCT00869570) | Swiss Cancer Institute | 2009-03-01 |
| Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers (NCT00853983) | AstraZeneca | 2009-03-01 |
| Comparison Between Low Carbohydrate Diet and Traditionally Recommended Diabetic Diet in the Treatment of Diabetes Mellitus Type 2. (NCT01005498) | Vårdcentralen Lyckorna | 2009-03-01 |
| CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia (NCT01013441) | University of Pennsylvania | 2009-03-01 |
| A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003) (NCT00886613) | Merck Sharp & Dohme LLC | 2009-03-01 |
| Phase I Study Evaluating The Safety And Efficacy of a Device for Collection of Electrical Bioimpedance Data (NCT00746915) | ImpediGuide Ltd | 2009-03-01 |
| Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma (NCT00694837) | Maastricht Radiation Oncology | 2009-03-01 |
| Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement (NCT00882180) | Alnylam Pharmaceuticals | 2009-03-01 |
| BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I (NCT00876460) | Boehringer Ingelheim | 2009-03-01 |
| Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis (NCT00890617) | Barbara Ann Karmanos Cancer Institute | 2009-03-01 |
| Testing of the Apnea Prevention Device (NCT00875134) | Oregon Health and Science University | 2009-03-01 |
| STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders (NCT00858572) | Synta Pharmaceuticals Corp. | 2009-03-01 |
| A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS (NCT00837785) | Biogen | 2009-02-28 |
| Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00601094) | Jonsson Comprehensive Cancer Center | 2009-02-26 |
| Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma (NCT00790010) | Dana-Farber Cancer Institute | 2009-02-26 |
| O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas (NCT00669669) | Fred Hutchinson Cancer Center | 2009-02-25 |
| Drug to Drug Interaction Study With ASP1941 and Metformin (NCT01302145) | Astellas Pharma Inc | 2009-02-25 |
| Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System (NCT00867178) | National Cancer Institute (NCI) | 2009-02-25 |
| Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) (NCT00866307) | Children's Oncology Group | 2009-02-23 |
| Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects (NCT00854009) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-02-20 |
| A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) (NCT00923247) | National Cancer Institute (NCI) | 2009-02-19 |
| Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors (NCT00837928) | John Grecula | 2009-02-19 |
| Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer (NCT00264602) | Dana-Farber Cancer Institute | 2009-02-18 |
| Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant (NCT00880815) | M.D. Anderson Cancer Center | 2009-02-17 |
| CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma (NCT00924326) | National Cancer Institute (NCI) | 2009-02-17 |
| Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma (NCT00841555) | Ohio State University Comprehensive Cancer Center | 2009-02-13 |
| Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098) (NCT00858234) | Merck Sharp & Dohme LLC | 2009-02-13 |
| Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate (NCT01046487) | Centre Oscar Lambret | 2009-02-09 |
| Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults (NCT00695877) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-08 |
| A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) (NCT00818259) | Merck Sharp & Dohme LLC | 2009-02-05 |
| A Study of the Effects of Single Dose Corticosteroids on Response to Allergens (NCT00828061) | Merck Sharp & Dohme LLC | 2009-02-04 |
| Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old (NCT00814762) | GlaxoSmithKline | 2009-02-03 |
| Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer (NCT00856037) | University of Nebraska | 2009-02-02 |
| Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) (NCT00840931) | H. Lee Moffitt Cancer Center and Research Institute | 2009-02-02 |
| Effect of Renal Impairment on the Pharmacokinetics of NN9535 (NCT00833716) | Novo Nordisk A/S | 2009-02-02 |
| Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma (NCT00860171) | Fred Hutchinson Cancer Center | 2009-02-01 |
| Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers. (NCT00932295) | Virginia Commonwealth University | 2009-02-01 |
| Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell (NCT02048540) | Chinese PLA General Hospital | 2009-02-01 |
| Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects (NCT02223832) | Actelion | 2009-02-01 |
| Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China (NCT00858325) | AstraZeneca | 2009-02-01 |
| A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects (NCT00825084) | Pfizer | 2009-02-01 |
| Efficacy and Safety of Anthrax Vaccine, GC1109 (NCT01867957) | Seoul National University Hospital | 2009-02-01 |
| Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis (NCT00847886) | Lexicon Pharmaceuticals | 2009-02-01 |
| Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025) (NCT00981487) | Forest Laboratories | 2009-02-01 |
| Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects (NCT01001013) | LG Life Sciences | 2009-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers (NCT02244203) | Boehringer Ingelheim | 2009-02-01 |
| AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer (NCT00719550) | Amgen | 2009-02-01 |
| AZD9164 Single Ascending Dose Study in Healthy Male Subjects (NCT00847249) | AstraZeneca | 2009-02-01 |